| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |